文献速递血栓与止血

肝病患者预防性输注新鲜冰冻血浆和血小板具有促血栓效应

Prophylactic fresh frozen plasma and platelet transfusion have a prothrombotic effect in patients with liver disease.
PubMed 文献 · J Thromb Haemost · 2020-12-25

该研究在真实临床场景中纳入19例拟预防性输注新鲜冰冻血浆(FFP)和13例拟输注血小板的肝病患者,于输血前后采血评估止血状态并与20名健康对照比较。结果显示FFP输注后体内外凝血酶生成显著增加,血小板输注后血小板计数升高并伴止血活化标志物上升,提示两种预防性输血均产生促血栓效应。

要点

  • 肝病患者的体外凝血酶生成在FFP输注前即保持良好
  • FFP输注后凝血酶生成指标显著升高,提示促血栓效应
  • 血小板输注后血小板计数上升并伴止血活化标志物增加

核心结论

  • FFP和血小板输注使肝病患者凝血酶生成增加、血小板计数升高,提示具有促血栓效应。
  • 所有输血是否真正有指征并产生临床相关效果仍存疑问。

研究设计与样本

  • 研究纳入19例经主治医师判定需预防性输注FFP的患者和13例拟在操作前输注血小板者。
  • 于输血前后采血评估止血状态,并与20名健康对照比较。

主要发现

  • 肝病患者FFP输注前体外凝血酶生成保持良好。
  • FFP输注后凝血酶-抗凝血酶复合物升高92%、凝血酶原片段1+2升高38%,内源性凝血酶潜力升高20%。
  • 血小板计数由输注前28[21-41]×10^9/L升至输注后43[39-64]×10^9/L(P<.01),并伴体内止血活化标志物升高。

临床怎么用

  • 肝病患者操作前预防性输注FFP或血小板需审慎评估指征,因可能带来促血栓效应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Patients with liver disease acquire complex changes in their hemostatic system, resulting in prolongation of the international normalized ratio and thrombocytopenia. Abnormalities in these tests are commonly corrected with fresh frozen plasma (FFP) or platelet transfusions before invasive procedures. Whether these prophylactic transfusions are beneficial and truly indicated is increasingly debated. In this study, we studied ex vivo effects of FFP and platelet transfusions in patients with liver disease-associated hemostatic changes in a real-life clinical setting. METHODS: We included 19 patients who were deemed to require prophylactic FFP transfusion by their treating physician and 13 that were prescribed platelet transfusion before a procedure. Hemostatic status was assessed in blood samples taken before and after transfusion and compared with healthy controls (n = 20). RESULTS: Ex vivo thrombin generation was preserved in patients with liver disease before FFP transfusion. Following FFP transfusion, both in and ex vivo thrombin generation significantly increased, as evidenced by a 92% and 38% increase in thrombin-antithrombin and prothrombin fragment 1 + 2 levels, respectively, and a 20% increase in endogenous thrombin potential. Platelet counts increased from 28 [21-41] × 109 /L before to 43 [39-64] × 109 /L after platelet transfusion (P < .01), and was accompanied by increases in in vivo markers of hemostatic activation. CONCLUSIONS: FFP and platelet transfusion resulted in increased thrombin generation and platelet counts in patients with liver disease, indicating a prothrombotic effect. However, whether all transfusions were truly indicated and had a clinically relevant effect is questionable.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. von Meijenfeldt FA, van den Boom BP, Adelmeijer J, et al. Prophylactic fresh frozen plasma and platelet transfusion have a prothrombotic effect in patients with liver disease. J Thromb Haemost. 2020. PMID: 33219597. doi:10.1111/jth.15185

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。